Clinical Trials Directory

Trials / Completed

CompletedNCT04161313

Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children

Comparison of Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With Cystic Fibrosis, Primary Ciliary Dyskinesia and Healthy Children

Status
Completed
Phase
Study type
Observational
Enrollment
76 (actual)
Sponsor
Bezmialem Vakif University · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to compare pulmonary function, respiratory muscle strength, exercise capacity and peripheral muscle strength of patients with CF, PCD and healthy childrens.

Detailed description

The impaired airway clearence and pulmonary functions, exercise intolerance, low physical activity level and decreased peripheral muscle strength make physiotherapy approaches important in the management of CF and PCD.

Conditions

Interventions

TypeNameDescription
OTHERMeasurement of functional capacityFunctional capacity of participants will be measured with six-minute walk test.
OTHERpulmonary function testIt will be measured using basic spirometry and presented lung volume parameters such as FEV1,FVC,FEV1/FVC,PEF, FEF25-75
OTHERFunctional capacityFunctional capacity of participants will be measured with six-minute walk test and sit-to-stand test
OTHERPeripheral muscle strengthIsometric M. Quadriceps strength will be measured using electronic hand held dynamometer in sitting position.
OTHERRespiratory muscle strengthInspiratory and expiratory muscle strength has been assessed by maximal inspiratory and expiratory mouth pressures.

Timeline

Start date
2019-12-20
Primary completion
2020-02-24
Completion
2020-03-12
First posted
2019-11-13
Last updated
2020-03-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04161313. Inclusion in this directory is not an endorsement.